JP2018065829A5 - - Google Patents

Download PDF

Info

Publication number
JP2018065829A5
JP2018065829A5 JP2017225061A JP2017225061A JP2018065829A5 JP 2018065829 A5 JP2018065829 A5 JP 2018065829A5 JP 2017225061 A JP2017225061 A JP 2017225061A JP 2017225061 A JP2017225061 A JP 2017225061A JP 2018065829 A5 JP2018065829 A5 JP 2018065829A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
treatment
subject
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017225061A
Other languages
English (en)
Japanese (ja)
Other versions
JP6419294B2 (ja
JP2018065829A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018065829A publication Critical patent/JP2018065829A/ja
Publication of JP2018065829A5 publication Critical patent/JP2018065829A5/ja
Application granted granted Critical
Publication of JP6419294B2 publication Critical patent/JP6419294B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017225061A 2010-07-20 2017-11-22 シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法 Active JP6419294B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36608010P 2010-07-20 2010-07-20
US61/366,080 2010-07-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016135208A Division JP2016199578A (ja) 2010-07-20 2016-07-07 シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法

Publications (3)

Publication Number Publication Date
JP2018065829A JP2018065829A (ja) 2018-04-26
JP2018065829A5 true JP2018065829A5 (enExample) 2018-07-05
JP6419294B2 JP6419294B2 (ja) 2018-11-07

Family

ID=45497167

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013520841A Pending JP2013531073A (ja) 2010-07-20 2011-07-20 シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法
JP2016135208A Pending JP2016199578A (ja) 2010-07-20 2016-07-07 シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法
JP2017225061A Active JP6419294B2 (ja) 2010-07-20 2017-11-22 シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2013520841A Pending JP2013531073A (ja) 2010-07-20 2011-07-20 シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法
JP2016135208A Pending JP2016199578A (ja) 2010-07-20 2016-07-07 シグマ受容体に仲介される障害を処置するための環状アミド誘導体の使用の方法

Country Status (15)

Country Link
US (4) US20130274290A1 (enExample)
EP (2) EP4070794A3 (enExample)
JP (3) JP2013531073A (enExample)
KR (1) KR101867634B1 (enExample)
CN (2) CN107007603A (enExample)
BR (1) BR112013001302A2 (enExample)
CA (2) CA3154027A1 (enExample)
DK (1) DK2595485T3 (enExample)
ES (1) ES2914120T3 (enExample)
HU (1) HUE058736T2 (enExample)
PL (1) PL2595485T3 (enExample)
PT (1) PT2595485T (enExample)
RU (2) RU2746871C2 (enExample)
TW (1) TWI520949B (enExample)
WO (1) WO2012012543A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8937900B2 (en) 2010-07-20 2015-01-20 Qualcomm Incorporated Enhancing pilot channel transmission in TD-SCDMA multicarrier systems using secondary carrier frequencies
US10179776B2 (en) 2014-06-09 2019-01-15 Intra-Cellular Therapies, Inc. Compounds and methods of use to treat schizophrenia
HUE058212T2 (hu) * 2014-12-02 2022-07-28 Minerva Neurosciences Inc 2-((1-(2(4-fluorfenil)-2-oxoetil)piperidin-4-il)metil)izoindolin-1-ont tartalmazó készítmények skizofrénia kezelésére
CN113908156A (zh) * 2016-05-25 2022-01-11 田边三菱制药株式会社 用于治疗非精神分裂症患者中的阴性症状的组合物和方法
IL308650B2 (en) 2017-06-21 2025-08-01 Minerva Neurosciences Inc Gastro-resistant controlled release oral dosage forms
EP3840835A1 (en) * 2018-08-21 2021-06-30 Minerva Neurosciences, Inc. Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection
EP4153209A1 (en) 2020-05-20 2023-03-29 The Board of Trustees of the University of Illinois Method for treating lysosomal storage diseases with histatin peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235841A (en) * 1989-10-27 1993-03-26 Du Pont (n-phthalimidoalkyl) piperidine derivatives and pharmaceutical compositions
CA2069318A1 (en) * 1989-10-27 1991-04-28 Engelbert Ciganek (n-phthalimidoalkyl) piperidines
PT637306E (pt) * 1992-04-23 2001-10-30 Merrell Pharma Inc 4-imidometil-1-¬2'-fenil-2'-oxoetil|-piperidinas como antagonistas 5ht2 da serotonina sua preparacao e sua utilizacao em terapeutica
AU2001234175B2 (en) * 2000-02-29 2004-10-07 Mitsubishi Pharma Corporation Novel cyclic amide derivatives
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them

Similar Documents

Publication Publication Date Title
JP2018065829A5 (enExample)
JP2016199578A5 (enExample)
JP2016528301A5 (enExample)
JP2015505564A5 (enExample)
JP2018193377A5 (enExample)
JP2018140982A5 (enExample)
JP2018021046A5 (enExample)
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
JP2006104221A5 (enExample)
JP2015187157A5 (enExample)
JP2017524735A5 (enExample)
JP2012193216A5 (enExample)
JP2016539157A5 (enExample)
JP2016510326A5 (enExample)
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
EA201692392A1 (ru) Новая лекарственная форма мелоксикама
PH12018502445A1 (en) Compositions and methods for treating negative symptoms in non-schizophrenic patients
JP2020529995A5 (enExample)
JP2013531073A5 (enExample)
JP2019500380A5 (enExample)
JP2019513812A5 (enExample)
RU2014151161A (ru) Метаболиты (1r-транс)-n-[[2-(2,3-дигидро-4-бензофуранил)циклопропил]-метил]пропанамида
JP2014058509A5 (enExample)
JP2017508004A5 (enExample)